AAAAAA

   
Results: 1-11 |
Results: 11
INHIBITION OF INTESTINAL MICROFLORA BETA-GLUCURONIDASE MODIFIES THE DISTRIBUTION OF THE ACTIVE METABOLITE OF THE ANTITUMOR AGENT, IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS
Authors: TAKASUNA K HAGIWARA T HIROHASHI M KATO M NOMURA M NAGAI E YOKOI T KAMATAKI T
Citation: K. Takasuna et al., INHIBITION OF INTESTINAL MICROFLORA BETA-GLUCURONIDASE MODIFIES THE DISTRIBUTION OF THE ACTIVE METABOLITE OF THE ANTITUMOR AGENT, IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS, Cancer chemotherapy and pharmacology, 42(4), 1998, pp. 280-286
INVOLVEMENT OF BETA-GLYCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE, IRINOTECAN (CPT-11), IN RATS
Authors: TAKASUNA K HAGIWARA T KAMATAKI T
Citation: K. Takasuna et al., INVOLVEMENT OF BETA-GLYCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE, IRINOTECAN (CPT-11), IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5434-5434
INVOLVEMENT OF CENTRAL OPIOID SYSTEMS IN INTERFERON-INDUCED ENHANCEMENT OF IMMOBILITY IN THE FORGED SWIMMING TEST IN MICE
Authors: MAKINO M KITANO Y KOMIYAMA C HIROHASHI M TAKASUNA K
Citation: M. Makino et al., INVOLVEMENT OF CENTRAL OPIOID SYSTEMS IN INTERFERON-INDUCED ENHANCEMENT OF IMMOBILITY IN THE FORGED SWIMMING TEST IN MICE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35171-35171
ENHANCEMENT OF IMMOBILITY IN MOUSE FORCED SWIMMING TEST BY TREATMENT WITH HUMAN INTERFERON
Authors: MAKINO M KITANO Y HIROHASHI M TAKASUNA K
Citation: M. Makino et al., ENHANCEMENT OF IMMOBILITY IN MOUSE FORCED SWIMMING TEST BY TREATMENT WITH HUMAN INTERFERON, European journal of pharmacology, 356(1), 1998, pp. 1-7
INCREASING-CURRENT ELECTROSHOCK SEIZURE TEST - A NEW METHOD FOR ASSESSMENT OF ANTI-CONVULSANT AND PRO-CONVULSANT ACTIVITIES OF DRUGS IN MICE
Authors: KITANO Y USUI C TAKASUNA K HIROHASHI M NOMURA M
Citation: Y. Kitano et al., INCREASING-CURRENT ELECTROSHOCK SEIZURE TEST - A NEW METHOD FOR ASSESSMENT OF ANTI-CONVULSANT AND PRO-CONVULSANT ACTIVITIES OF DRUGS IN MICE, Journal of pharmacological and toxicological methods, 35(1), 1996, pp. 25-29
INVOLVEMENT OF BETA-GLUCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS
Authors: TAKASUNA K HAGIWARA T HIROHASHI M KATO M NOMURA M NAGAI E YOKOI T KAMATAKI T
Citation: K. Takasuna et al., INVOLVEMENT OF BETA-GLUCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS, Cancer research, 56(16), 1996, pp. 3752-3757
PROTECTIVE EFFECTS OF KAMPO MEDICINES AND BAICALIN AGAINST INTESTINALTOXICITY OF A NEW ANTICANCER CAMPTOTHECIN DERIVATIVE, IRINOTECAN HYDROCHLORIDE (CPT-11), IN RATS
Authors: TAKASUNA K KASAI Y KITANO Y MORI K KOBAYASHI R HAGIWARA T KAKIHATA K HIROHASHI M NOMURA M NAGAI E KAMATAKI T
Citation: K. Takasuna et al., PROTECTIVE EFFECTS OF KAMPO MEDICINES AND BAICALIN AGAINST INTESTINALTOXICITY OF A NEW ANTICANCER CAMPTOTHECIN DERIVATIVE, IRINOTECAN HYDROCHLORIDE (CPT-11), IN RATS, Japanese journal of cancer research, 86(10), 1995, pp. 978-984
NEFIRACETAM, A NOVEL COGNITION-ENHANCING AGENT - AN INTRODUCTORY OVERVIEW
Authors: TANAKA M TAKASUNA K TAKAYAMA S
Citation: M. Tanaka et al., NEFIRACETAM, A NOVEL COGNITION-ENHANCING AGENT - AN INTRODUCTORY OVERVIEW, Arzneimittel-Forschung, 44-1(2A), 1994, pp. 193-194
GENERAL PHARMACOLOGICAL PROFILE OF THE NEW COGNITION-ENHANCING AGENT NEFIRACETAM
Authors: KITANO Y MAKINO M USUI C TAKASUNA K KASAI Y HIROHASHI M TAMURA K TAKAYAMA S KOJIMA H IIZUKA H YANAGITA T
Citation: Y. Kitano et al., GENERAL PHARMACOLOGICAL PROFILE OF THE NEW COGNITION-ENHANCING AGENT NEFIRACETAM, Arzneimittel-Forschung, 44-1(2A), 1994, pp. 199-210
GENERAL PHARMACOLOGICAL PROFILE OF THE NEW ANTIULCER DRUG YL)ETHYL]CARBAMOYL]METHYL]-AMINO-N-METHYLBENZAMIDE
Authors: HIROHASHI M TAKASUNA K KASAI Y USUI C TAMURA K KOJIMA H
Citation: M. Hirohashi et al., GENERAL PHARMACOLOGICAL PROFILE OF THE NEW ANTIULCER DRUG YL)ETHYL]CARBAMOYL]METHYL]-AMINO-N-METHYLBENZAMIDE, Arzneimittel-Forschung, 43-1(5), 1993, pp. 569-577
CARDIOVASCULAR PROPERTIES OF THE NEW ANTIULCER DRUG YL)ETHYL]CARBAMOYL]METHYL]-AMINO-N-METHYLBENZAMIDE
Authors: HIROHASHI M TAKASUNA K ASANO M RYOKAWA Y TAMURA K
Citation: M. Hirohashi et al., CARDIOVASCULAR PROPERTIES OF THE NEW ANTIULCER DRUG YL)ETHYL]CARBAMOYL]METHYL]-AMINO-N-METHYLBENZAMIDE, Arzneimittel-Forschung, 43-1(5), 1993, pp. 578-583
Risultati: 1-11 |